Next-Generation Diagnostics: Integrating Smart Nanoprobes with Advanced Signal Amplification

The accurate early detection and precise localization of diseases remain pivotal challenges in modern medicine. Traditional diagnostic methods often grapple with limitations in sensitivity, specificity, particularly for ultra-rare, low-abundance biomarkers at the initial stages of pathological development. The convergence of nanotechnology and molecular biology has ushered in a transformative era, with nanoprobes emerging as powerful agents for sensing and imaging. These nanoscale tools offer unique advantages, including high surface-area-to-volume ratios, tunable surface chemistry, and the ability to interface with biological systems. When integrated with advanced signal amplification techniques—a cornerstone of molecular diagnostics—these nanoprobes can achieve extraordinary signal enhancement, pushing the boundaries of detectability for the most elusive molecular targets. This interdisciplinary synergy is forming the foundation for a new paradigm in ultra-sensitive diagnostics, aiming to move beyond mere detection towards quantitative, multiplexed, and spatially resolved analysis of critical but rare disease signatures.The central goal of this Research Topic is to address the critical need for highly sensitive, specific, and clinically actionable diagnostic platforms capable of detecting ultra-rare biomarkers. This will be achieved by exploring and advancing three interconnected fronts: smart nanoprobes, novel signal amplification strategies, and their sophisticated integration. We aim to tackle key problems such as the reliable detection of ultra-rare molecular targets (e.g., circulating tumor DNA, microRNAs, low-copy number pathogens or proteins), real-time monitoring of disease progression in vivo, and the development of robust point-of-care systems. Recent advances provide a powerful toolkit to achieve these aims. This includes the design of stimuli-responsive or "smart" nanoprobes that activate only in the presence of a disease-specific trigger, novel nanocarriers for the delivery of amplification components, and the revolutionary integration of isothermal amplification techniques (e.g., RPA, LAMP) and CRISPR-Cas systems with nanomaterial-based signal transducers. We seek to compile research that not only demonstrates superior analytical performance for ultra-rare targets but also rigorously addresses challenges related to biosystem compatibility, multiplexing capability, quantitative accuracy, and translational potential, thereby bridging the gap between proof-of-concept innovation and practical diagnostic application.This Research Topic welcomes high-quality contributions that focus on the design, development, and application of integrated nanoprobe-amplification systems for the detection (biosensing or bioimaging) of ultra-rare biomarkers in disease diagnostics. Specific themes of interest include, but are not limited to:• Novel designs of smart, activatable, or multiplexed nanoprobes for ultra-rare biomarker detection.• Innovative signal amplification strategies (enzymatic, nanomaterial-enhanced, hybridization chain reaction, CRISPR-based) coupled with nanoprobes to achieve extreme sensitivity.• Integrated platforms for high-sensitivity simultaneous detection and imaging (in vitro or in vivo).• Point-of-care diagnostic devices incorporating nanomaterials and amplification for low-abundance target analysis.• Applications focused on diagnosing diseases through ultra-rare biomarkers in infectious diseases and cancers.• Studies addressing ultra-high sensitivity, specificity, scalability, and clinical validation of these new platforms.We encourage the submission of Original Research articles, Reviews, Mini-Reviews, Perspectives, and Method papers that present significant conceptual or technological advances in this dynamic field. Contributions that emphasize interdisciplinary approaches, focus on ultra-rare biomarker detection, and highlight translational potential are particularly welcome. Topic editors: Hai Shi, Ying Peng, Bailiang Wang, Tianyu Zeng, Liu Shi Source: https://www.frontiersin.org/research-topics/77057/next-generation-diagnostics-integrating-smart-nanoprobes-with-advanced-signal-amplification